Ledger.Open graph →

SEC Form D · filed December 18, 2025

KAZIA THERAPEUTICS LTD

Offering

$55.3M

Sold

$55.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SYDNEY NSW, Channel Islands

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jeffrey Bonacorda · Sydney, Channel IslandsExec Steven Coffey · Sydney, Channel IslandsDirector Ebru Davidson · Sydney, Channel IslandsDirector John Friend · Sydney, Channel IslandsExec Elissa Hansen · Sydney, Channel IslandsExec Bryce Carmine · Sydney, Channel IslandsDirector Robert Apple · Sydney, Channel IslandsDirector John Friend · Sydney, Channel IslandsExec Bryce Carmine · Sydney, Channel IslandsDirector Jeffrey Bonacorda · Sydney, Channel IslandsExec Ebru Davidson · Sydney, Channel IslandsDirector Robert Apple · Sydney, Channel IslandsDirector Elissa Hansen · Sydney, Channel IslandsExec Steven Coffey · Sydney, Channel IslandsDirector James Ruggerio · Chatham, NJDirector Craig Stilwell · Osceola, IAExec Robert Taylor · Osceola, IAExec Christina Taylor · Osceola, IADirector Chad Terry · Osceola, IADirector Todd G. Rapp · New York, NYDirector Jeff G. Runnfeldt · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗